These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37287257)

  • 1. Choice of intrapleural fibrinolytic agents in the treatment of adult complicated parapneumonic effusion and empyema: Network meta-analysis.
    Yokoyama Y; Kuno T; Takagi H; Burfeind W
    Asian Cardiovasc Thorac Ann; 2023 Jun; 31(5):451-458. PubMed ID: 37287257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
    Altmann ES; Crossingham I; Wilson S; Davies HR
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
    Khemasuwan D; Sorensen J; Griffin DC
    Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials.
    Nie W; Liu Y; Ye J; Shi L; Shao F; Ying K; Zhang R
    Clin Respir J; 2014 Jul; 8(3):281-91. PubMed ID: 24428897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapleural Thrombolytics for Parapneumonic Effusion: A Network Metaanalysis.
    Sridharan K; Sivaramakrishnan G
    Curr Rev Clin Exp Pharmacol; 2024; 19(2):204-212. PubMed ID: 36173062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-pleural fibrinolytic therapy vs. conservative management in the treatment of parapneumonic effusions and empyema.
    Cameron R
    Cochrane Database Syst Rev; 2000; (3):CD002312. PubMed ID: 10908554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the outcomes of intrapleural fibrinolytic and DNase therapy versus intrapleural fibrinolytic or DNase therapy: A systematic review and meta-analysis.
    Chong WH; Hu K; Saha BK; Chopra A
    Pulm Pharmacol Ther; 2021 Dec; 71():102081. PubMed ID: 34571093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema.
    Cameron R; Davies HR
    Cochrane Database Syst Rev; 2008 Apr; (2):CD002312. PubMed ID: 18425881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Intrapleural Sepsis with Once Daily Use of Tissue Plasminogen Activator and Deoxyribonuclease.
    Mehta HJ; Biswas A; Penley AM; Cope J; Barnes M; Jantz MA
    Respiration; 2016; 91(2):101-6. PubMed ID: 26761711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis.
    Tokuda Y; Matsushima D; Stein GH; Miyagi S
    Chest; 2006 Mar; 129(3):783-90. PubMed ID: 16537882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrapleural tissue plasminogen activator and deoxyribonuclease administered concurrently and once daily for complex parapneumonic pleural effusion and empyema.
    Smith D; Shaw H; Ryder T
    Intern Med J; 2023 Dec; 53(12):2313-2318. PubMed ID: 37029951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.
    Livingston MH; Mahant S; Connolly B; MacLusky I; Laberge S; Giglia L; Yang C; Roberts A; Shawyer A; Brindle M; Parsons S; Stoian C; Walton JM; Thorpe KE; Chen Y; Zuo F; Mamdani M; Chan C; Loong D; Isaranuwatchai W; Ratjen F; Cohen E
    JAMA Pediatr; 2020 Apr; 174(4):332-340. PubMed ID: 32011642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema.
    Cameron R; Davies HR
    Cochrane Database Syst Rev; 2004; (2):CD002312. PubMed ID: 15106174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
    Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
    Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
    Israel EN; Blackmer AB
    Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapleural Thrombolytics as First Line Therapy for Complicated Parapneumonic Effusions and Empyema in Patients with Prohibitive Surgical Risk: A Cases Series.
    Morales-Colón S; Rivera-Agosto MM; Mercader-Pérez M; Cantres-Contreras O; Rodríguez-Cintrón W
    P R Health Sci J; 2023 Sep; 42(3):241-245. PubMed ID: 37709682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrapleural streptokinase for the treatment of complicated parapneumonic effusion and empyema in 2 newborns.
    Yigit AK; Yilmaz Y; Erdeve O; Gokce IK; Oguz SS; Uras N; Dilmen U
    J Pediatr Surg; 2012 Oct; 47(10):e41-4. PubMed ID: 23084230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.
    Singh G; Pitoyo CW; Nasir AU; Rumende CM; Amin Z
    Acta Med Indones; 2012 Jul; 44(3):258-64. PubMed ID: 22983084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study-2: Use of 2.5 mg alteplase as a starting intrapleural dose.
    Popowicz N; Ip H; Lau EPM; Piccolo F; Dootson K; Yeoh C; Phu WY; Brown R; West A; Ahmed L; Lee YCG
    Respirology; 2022 Jul; 27(7):510-516. PubMed ID: 35441458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrapleural Fibrinolytics and Deoxyribonuclease for Treatment of Indwelling Pleural Catheter-Related Pleural Infection: A Multi-Center Observational Study.
    Fitzgerald DB; Muruganandan S; Tsim S; Ip H; Asciak R; Walker S; Uribe Becerra JP; Majid A; Ahmed L; Rahman NM; Maskell NA; Blyth KG; Lee YCG
    Respiration; 2021; 100(5):452-460. PubMed ID: 33784710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.